Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dose-dependent increase or decrease of somatic intrachromosomal recombination produced by etoposide.

Antony M Hooker1, Rachel Horne, Alexander A Morley

  • 1Department of Haematology and Genetic Pathology, Flinders University of South Australia and Flinders Medical Centre, Bedford Park, SA 5042, Australia.

Mutation Research
|March 14, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanistic Effects of Environmental and Medical Low-Dose Radiation Exposure of the Lung.

Biomedicines·2026
Same author

A rapid evaluation of the reporting and publishing practices of patient and public involvement and engagement in health research within a UK university institute.

Research involvement and engagement·2026
Same author

Immunological and Respiratory Effects in a Healthy Rodent Model after Inhalation of Low and Regulated Levels of Radon.

Radiation research·2025
Same author

Nothing about us, without us - establishing a patient and public involvement and engagement group.

Nature reviews. Neurology·2025
Same author

Prevention Is Better Than Cure: Public Understanding of Preventing Neurodegenerative Disorders.

International journal of geriatric psychiatry·2025
Same author

Diversity and representation within the literature on sexual dysfunction in multiple sclerosis: A systematic review.

Multiple sclerosis and related disorders·2024
Same journal

Monoallelic germline RAD51C, RAD51D, and BRIP1 variants in hereditary cancer testing: Variant spectrum and clinical counselling implications.

Mutation research·2026
Same journal

Prediction of hepatocellular carcinoma associated biomarkers in TP53 gene; A comprehensive in silico analysis.

Mutation research·2026
Same journal

IDH1 mutation promotes angiogenesis via upregulation of hypoxia inducible factor 1 alpha in glial tumors.

Mutation research·2026
Same journal

Targeting overexpressed oncogenes in esophageal cancer through miRNA-mediated gene silencing: Insights from binding affinity and thermodynamic profiling.

Mutation research·2026
Same journal

The active compound quercetin from Polygonum cuspidatum targets COL3A1 to enhance CD8⁺ T cell cytotoxicity in gastric cancer.

Mutation research·2026
Same journal

E2F1 promotes LIHC malignant phenotype via NEK2-mediated Wnt/β-catenin and Notch activation and EMT.

Mutation research·2026
See all related articles

Etoposide treatment affects somatic intrachromosomal recombination (SICR) in a dose-dependent manner. Low doses of etoposide suppress SICR, while higher doses induce it, impacting mutagenesis and carcinogenesis research.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • Somatic intrachromosomal recombination (SICR) drives chromosomal alterations like inversions and deletions.
  • SICR plays a critical role in mutagenesis and the development of cancer.

Purpose of the Study:

  • To investigate the dose-dependent effects of etoposide on SICR frequency in vivo and in vitro.
  • To elucidate the mechanism behind etoposide's influence on recombination suppression at low doses.

Main Methods:

  • Utilized the pKZ1 mouse mutagenesis model for in vivo studies.
  • Administered varying doses of etoposide intraperitoneally to mice and analyzed spleen tissue.
  • Exposed a pKZ1 mouse hybridoma cell line to etoposide in vitro and assessed SICR inversion frequencies.

Related Experiment Videos

Main Results:

  • Etoposide treatment (0.05-50 mg/kg) significantly induced SICR inversions (1.4-3.1-fold) in pKZ1 mice.
  • Low etoposide doses (0.0005-0.005 mg/kg) significantly decreased SICR inversion frequencies (0.67-0.43-fold) in vivo.
  • In vitro studies mirrored in vivo findings, showing SICR induction at high etoposide concentrations (100-1000 nM) and suppression at low concentrations (1-10 nM).

Conclusions:

  • Etoposide exhibits a biphasic dose-dependent effect on SICR, inducing it at high doses and suppressing it at low doses.
  • The observed reduction in SICR at low etoposide concentrations is not due to a kinetic phenomenon.
  • Further research is needed to determine the precise mechanism and implications of etoposide-induced recombination suppression.